Pharmaceutical Manufacturing Market & COVID-19 Assessment 2020 - ResearchAndMarkets.com

DUBLIN--()--The "Pharmaceutical Manufacturing - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering.

The Global Pharmaceutical Manufacturing Market is expected to grow at a CAGR of 7% during the forecast period.

Increasing prevalence of chronic diseases and the growing demand for medications are the major factors propelling the market growth. However, high initial cost and stringent government regulations are restraining the market growth.

Based on the formulation, the injectables segment is having a lucrative growth during the forecast period due to the ongoing researches for developing new drugs and the growing use of sterile products in medical sector. By geography, Asia-Pacific is going to have a lucrative growth during the forecast period due to owing to less cost, healthier way of life, higher disposal incomes, growth of generics, high efficiency and low cost of labour.

Some of the key players profiled in the Pharmaceutical Manufacturing Market include Takeda, Sanofi, Roche, Pfizer, Novo Nordisk, Novartis, Lupin, GlaxoSmithKline, Gilead Sciences, Eli Lily, Merck & Co., Cipla, Astra Zeneca, Amgen, Actavis and Abbott Laboratories.

What the report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Key Topics Covered

1 Executive Summary

2 Preface

3 Market Trend Analysis

3.1 Introduction

3.2 Drivers

3.3 Restraints

3.4 Opportunities

3.5 Threats

3.6 End-user Analysis

3.7 Emerging Markets

3.8 Impact of COVID-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

4.4 Threat of new entrants

4.5 Competitive rivalry

5 Global Pharmaceutical Manufacturing Market, By Formulation

5.1 Introduction

5.2 Tablets

5.3 Syrups

5.4 Suspensions

5.5 Powders

5.6 Injectables

5.7 Emulsions

5.8 Capsules

6 Global Pharmaceutical Manufacturing Market, By Route of Administration

6.1 Introduction

6.2 Topical

6.3 Parenteral

6.4 Oral

6.5 Inhalations

6.6 Enteral

7 Global Pharmaceutical Manufacturing Market, By Prescription Requirement

7.1 Introduction

7.2 OTC (Over the Counter) Medicines

7.3 Prescription Medicines

8 Global Pharmaceutical Manufacturing Market, By Disease

8.1 Introduction

8.2 Respiratory Disease Treatment

8.3 Renal

8.4 Neurological

8.5 Cardiovascular

8.6 Cancer

9 Global Pharmaceutical Manufacturing Market, By End-user

9.1 Introduction

9.2 Pregnant Women

9.3 Pediatrics

9.4 Neonates

9.5 Geriatrics

9.6 Adults

10 Global Pharmaceutical Manufacturing Market, By Geography

10.1 Introduction

10.2 North America

10.2.1 US

10.2.2 Canada

10.2.3 Mexico

10.3 Europe

10.3.1 Germany

10.3.2 UK

10.3.3 Italy

10.3.4 France

10.3.5 Spain

10.3.6 Rest of Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 New Zealand

10.4.6 South Korea

10.4.7 Rest of Asia-Pacific

10.5 South America

10.5.1 Argentina

10.5.2 Brazil

10.5.3 Chile

10.5.4 Rest of South America

10.6 Middle East & Africa

10.6.1 Saudi Arabia

10.6.2 UAE

10.6.3 Qatar

10.6.4 South Africa

10.6.5 Rest of Middle East & Africa

11 Key Developments

11.1 Agreements, Partnerships, Collaborations and Joint Ventures

11.2 Acquisitions & Mergers

11.3 New Product Launch

11.4 Expansions

11.5 Other Key Strategies

12 Company Profiling

12.1 Takeda

12.2 Sanofi

12.3 Roche

12.4 Pfizer

12.5 Novo Nordisk

12.6 Novartis

12.7 Lupin

12.8 GlaxoSmithKline

12.9 Gilead Sciences

12.10 Eli Lilly Merck & Co.

12.11 Cipla

12.12 Astra Zeneca

12.13 Amgen

12.14 Actavis

12.15 Abbott Laboratories

For more information about this report visit https://www.researchandmarkets.com/r/e1ma65

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900